Week Ending February 28, 2022

UVA Cancer Center discovery suggests new treatment for deadly lung cancer
“An unexpected discovery at UVA Cancer Center has allowed scientists to halt the development of small-cell lung cancer in lab mice, and the surprise finding could open the door to a new treatment approach in people.”

Study Finds Decline in Global Lung Cancer Clinical Trial Enrollment During COVID-19
“Throughout the COVID-19 pandemic, enrollment in lung cancer clinical trials fell by 14% globally, according to new research published in the Journal of Thoracic Oncology.”

Dana-Farber’s Sands: More Lung Screening Would Have Greatest Impact on Cancer Mortality
“Jacob Sands, MD, who leads the small cell lung cancer research program at Dana-Farber Cancer Institute, speaks with The American Journal of Managed Care (AJMC®) about the need for more patients who meet the criteria for lung screening to catch cancer before it reaches an advanced stage.”

TERAVOLT Study Identifies 7 Factors Associated with COVID-19 Mortality in Thoracic Cancer
“The TERAVOLT study identified 7 factors associated with increased mortality risk for patients with thoracic malignancies who have contracted COVID-19.”

How Employers Can Achieve High-Value, Cost-Effective Oncology Care Through Genomic Profiling
“With US spending on oncology care having doubled since 2013, a webinar by the National Cancer Treatment Alliance, an initiative of the Community Oncology Alliance (COA), discussed how employers can leverage biomarker testing to avoid unnecessary treatment costs and eliminate waste.”

What Are Paraneoplastic Syndromes in Lung Cancer?
“Paraneoplastic syndromes are rare groups of symptoms that affect some people with cancer.”

Medicare and Medicaid Coverage for Lung Cancer Patients
“Regardless of the cause of lung cancer, one thing remains true. Without the ability to detect these cancers early and without the means to treat them, more people will have poor outcomes.”

The Future of AI and Lung Cancer Screening, A Conversation with Jae Ho Sohn, MD, MS
“The primary purpose of lung cancer screening is to analyze the high-risk patient population to catch signs of cancer early. Jae Ho Sohn, MD, MS, assistant professor in the Cardiac and Pulmonary Imaging Section in the UC San Francisco Department of Radiology and Biomedical Imaging is engaged in a number of research projects including lung cancer risk stratification in lung cancer screening.”

Do 2021 USPSTF Lung Cancer Screening Criteria Eliminate Racial Disparities?
“The 2021 US Preventive Services Task Force (USPSTF) guideline for lung cancer screening broadens eligibility for screening and decreases the racial disparity in access to screening, thus resolving significant issues present in earlier, fixed screening criteria. This was among study findings recently published in JAMA Oncology.”